buprenorphine transdermal system

Product NDC
64380-145
11-digit product format
643800145
Labeler code
64380
Product ID
64380-145_1a9a0478-c079-41a2-9662-c1616ce59e43
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
buprenorphine
Dosage form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Labeler
Strides Pharma Science Limited
Application
ANDA207490
Marketing category
ANDA
Marketing start
2026-11-16
Substance
BUPRENORPHINE
Active strength
10 ug/1
Pharmacologic classes
Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
DEA schedule
CIII
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A207490-001BUPRENORPHINEBUPRENORPHINE5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17
A207490-002BUPRENORPHINEBUPRENORPHINE10MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17
A207490-003BUPRENORPHINEBUPRENORPHINE15MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17
A207490-004BUPRENORPHINEBUPRENORPHINE20MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17
A207490-005BUPRENORPHINEBUPRENORPHINE7.5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMAL2023-03-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A207490-001AB
A207490-002AB
A207490-003AB
A207490-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 159 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A207490-001BUPRENORPHINE5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17d4dbc9d85df4…
2026-11-14 07:37:172026-10A207490-002BUPRENORPHINE10MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17d4dbc9d85df4…
2026-11-14 07:37:172026-10A207490-003BUPRENORPHINE15MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17d4dbc9d85df4…
2026-11-14 07:37:172026-10A207490-004BUPRENORPHINE20MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17d4dbc9d85df4…
2026-11-14 07:37:172026-10A207490-005BUPRENORPHINE7.5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMAL2023-03-21d4dbc9d85df4…
2026-10-15 13:18:302026-09A207490-001BUPRENORPHINE5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17c2088c7a36db…
2026-10-15 13:18:302026-09A207490-002BUPRENORPHINE10MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17c2088c7a36db…
2026-10-15 13:18:302026-09A207490-003BUPRENORPHINE15MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17c2088c7a36db…
2026-10-15 13:18:302026-09A207490-004BUPRENORPHINE20MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17c2088c7a36db…
2026-10-15 13:18:302026-09A207490-005BUPRENORPHINE7.5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMAL2023-03-21c2088c7a36db…
2026-09-14 22:38:342026-08A207490-001BUPRENORPHINE5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-1784e616aacf4f…
2026-09-14 22:38:342026-08A207490-002BUPRENORPHINE10MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-1784e616aacf4f…
2026-09-14 22:38:342026-08A207490-003BUPRENORPHINE15MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-1784e616aacf4f…
2026-09-14 22:38:342026-08A207490-004BUPRENORPHINE20MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-1784e616aacf4f…
2026-09-14 22:38:342026-08A207490-005BUPRENORPHINE7.5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMAL2023-03-2184e616aacf4f…
2026-08-18 06:07:402026-07A207490-001BUPRENORPHINE5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17caaa826d4ba7…
2026-08-18 06:07:402026-07A207490-002BUPRENORPHINE10MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17caaa826d4ba7…
2026-08-18 06:07:402026-07A207490-003BUPRENORPHINE15MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17caaa826d4ba7…
2026-08-18 06:07:402026-07A207490-004BUPRENORPHINE20MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17caaa826d4ba7…
2026-08-18 06:07:402026-07A207490-005BUPRENORPHINE7.5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMAL2023-03-21caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A207490-001BUPRENORPHINE5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A207490-002BUPRENORPHINE10MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A207490-003BUPRENORPHINE15MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A207490-004BUPRENORPHINE20MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A207490-005BUPRENORPHINE7.5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMAL2023-03-21011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207490-001BUPRENORPHINE5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207490-002BUPRENORPHINE10MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207490-003BUPRENORPHINE15MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207490-004BUPRENORPHINE20MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207490-005BUPRENORPHINE7.5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMAL2023-03-2131067a03dcf5…
2025-08-23 18:47 UTC2025-08A207490-001BUPRENORPHINE5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A207490-002BUPRENORPHINE10MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A207490-003BUPRENORPHINE15MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A207490-004BUPRENORPHINE20MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A207490-005BUPRENORPHINE7.5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMAL2023-03-216a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207490-001BUPRENORPHINE5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207490-002BUPRENORPHINE10MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207490-003BUPRENORPHINE15MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207490-004BUPRENORPHINE20MCG/HRFILM, EXTENDED RELEASE / TRANSDERMALAB2022-05-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207490-005BUPRENORPHINE7.5MCG/HRFILM, EXTENDED RELEASE / TRANSDERMAL2023-03-21fd3edfee7708…

Observed Orange Book normalized TE history#

Normalized TE history page 3 of 4 · 135 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2024-02-18 07:12 UTC2024-02A207490-001AB11c564ffb4f44…
2024-02-18 07:12 UTC2024-02A207490-002AB11c564ffb4f44…
2024-02-18 07:12 UTC2024-02A207490-003AB11c564ffb4f44…
2024-02-18 07:12 UTC2024-02A207490-004AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A207490-001AB1ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12A207490-002AB1ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12A207490-003AB1ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12A207490-004AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A207490-001AB1a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A207490-002AB1a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A207490-003AB1a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A207490-004AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A207490-001AB19b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A207490-002AB19b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A207490-003AB19b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A207490-004AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A207490-001AB1a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A207490-002AB1a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A207490-003AB1a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A207490-004AB1a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A207490-005AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A207490-001AB13f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A207490-002AB13f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A207490-003AB13f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A207490-004AB13f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A207490-005AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A207490-001AB1053a50430f4f…
2023-05-13 08:27 UTC2023-05A207490-002AB1053a50430f4f…
2023-05-13 08:27 UTC2023-05A207490-003AB1053a50430f4f…
2023-05-13 08:27 UTC2023-05A207490-004AB1053a50430f4f…
2023-05-13 08:27 UTC2023-05A207490-005AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A207490-001AB13bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01A207490-002AB13bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01A207490-003AB13bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01A207490-004AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A207490-001AB13a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A207490-002AB13a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A207490-003AB13a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A207490-004AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A207490-001AB1f41ea6bd6efb…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
buprenorphine transdermal systemBUPRENORPHINEAlvogen Inc.315284b8-32ab-d34a-ea02-f501c6131bcc2025-09-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 207490
application number: ANDA207490

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
64380-145-02643800145024 POUCH in 1 CARTON (64380-145-02) / 1 PATCH, EXTENDED RELEASE in 1 POUCH (64380-145-01) 4 pouch2026-11-16NoNoHistorical